Lantheus Holdings, a company focusing on radiopharmaceuticals, is considering a possible sale after receiving a takeover offer from Curium Pharma, a private equity firm, valued
Category: Health
London’s GHO and Singapore’s CBC $21 billion deal will create the world’s largest healthcare investor.
Global Healthcare Opportunities (GHO), based in London, and CBC Group, located in Singapore, announced on Wednesday that they will combine to form what they described
The Geneva-based Global Fund to Combat AIDS, Malaria, and Tuberculosis gets $11 billion from world leaders.
At an event in Johannesburg on Friday, a global health program that fights AIDS, TB, and malaria raised $11.34 billion, falling short of its goal
AI nurses are transforming hospital treatment in the US and set to replace 190, 000 human nurses.
Someone like Ana, who can help you get ready for your visit and answer any urgent questions you may have, might call you the next
The U.S. considers WHO membership with American leadership.
The Trump administration has been mulling a plan to overhaul the World Health Organization, which would include placing an American in leadership, to keep the
Big Tobacco offers payment of $24b to smokers to settle Canada lawsuits.
As part of a court-appointed mediator’s proposed plan, cigarette manufacturers Philip Morris, British American Tobacco, and Japan Tobacco will pay C$32.5 billion ($23.6 billion) to
J&J bolsters its MedTech unit with a $13b Shockwave deal.
By spending almost $13 billion to acquire Shockwave Medical, a company that develops technologies to assist open blocked arteries, Johnson & Johnson is increasing its
Gottesman’s widow donates $1b to a New York medical school, the highest on record.
Samuel Woo, a first-year student, was thinking about going into cardiology so he could pay off his medical school debt, but last week he learned
Drugmaker Bristol Myers Squibb to boost neuroscience portfolio with acquisition of Karuna Therapeutics in $14b deal
In a $14 billion transaction, pharmaceutical giant Bristol Myers Squibb will purchase biopharmaceutical startup Karuna Therapeutics, which has created a novel antipsychotic. Karuna and Bristol
AbbVie Pharmaceuticals diversifies into ovarian cancer drug with the acquisition of ImmunoGen for $10.1b.
To expedite the pharmaceutical company’s entry into the ovarian cancer therapy market, AbbVie is purchasing ImmunoGen in a deal estimated to be worth $10.1 billion.
Load More
